| Literature DB >> 35898696 |
Yaxiu Feng1, Ching Han Young1,2, Siu Hin Lau1, Ming-Liang He1,3.
Abstract
The control management of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections is one of the most challenges in the 21st century. By May 8th, 2022, SARS-CoV-2 has infected over 510 million people with 6.2 million death worldwide and over 1.2 million people with 9133 deaths in the fifth wave of infection in Hong Kong. The government responded rapidly in the early days of the 2020 outbreak, and the results were encouraging to control COVID-19 outbreak unavailable of vaccine. The quick responses to the epidemic alerts, for example, public education and control policies, kept residents safe from infection in the city with such a high population density and large-scale travelers. Nevertheless, the extremely high infectivity, Omicron variant infections, and the shortcomings of transmission control measures led to uncontrollable outbreak in 2022. The weak immunity groups, elderly and children, experienced a high hospitalization rate and mortality rate because of low vaccination rate. Currently, the infection is under well controlled. This study timely summarizes the challenges, policy, and lessons of SARS-CoV-2 outbreak control from 2020 to 2022. More importantly, the lesson and policy revealed from this study may be beneficial and applied to other cities with the outbreak of highly infectious SARS-CoV-2.Entities:
Keywords: Omicron variant; SARS‐CoV‐2; infection control; outbreak management
Year: 2022 PMID: 35898696 PMCID: PMC9309738 DOI: 10.1002/mco2.158
Source DB: PubMed Journal: MedComm (2020) ISSN: 2688-2663
FIGURE 1The cumulative confirmed COVID‐19 cases and deaths
Vaccine coverage and the COVID‐19 infected death in Hong Kong by the end of 2021
| No. of deaths with no. of vaccine doses (% of total death | ||||||
|---|---|---|---|---|---|---|
| Age group | End‐2021 resident population | Received 2 doses end‐2021 (% of total | Cumulative number of deaths (% of total death) | None | 1 | 2 |
| <3 | 123,600 | NA | 1(0.0) | 1 (100) | 0 | 0 |
| 3–19 | 949,900 | 255,510 (26.9) | 10(0.2) | 6 (60.0) | 4 (40.0) | 0 |
| 20–29 | 771,900 | 613,586 (79.5) | 10(0.2) | 6 (60.0) | 2 (20.0) | 2 (20.0) |
| 30–39 | 1,094,500 | 864,294 (79.0) | 15(0.3) | 9 (60.0) | 2 (13.3) | 4 (26.7) |
| 40–49 | 1,160,300 | 963,035 (83.0) | 43 (0.7) | 30 (69.8) | 4 (9.3) | 9 (20.9) |
| 50–59 | 1,191,300 | 924,587 (77.6) | 170 (2.9) | 95 (55.9) | 34 (20.0) | 41 (24.1) |
| 60–69 | 1,122,100 | 679,592 (60.6) | 496 (8.4) | 309 (62.3) | 94 (19.0) | 93 (18.8) |
| 70–79 | 591,300 | 253,378 (42.9) | 977 (16.5) | 625 (64.0) | 201 (20.6) | 151 (15.5) |
| ≥80 | 398,200 | 71,635 (18.0) | 4182 (70.8) | 3036 (72.6) | 728 (17.4) | 418 (10.0) |
|
|
|
|
|
|
|
|
Rate to the total in each age group.
(All the data are from https://www.coronavirus.gov.hk/chi/index.html#Updates_on_COVID‐19_Situation).
The cumulative death and associated vaccination status of different age group in Hong Kong by May 8, 2022
| Age groups | End‐2021 resident population | Received two doses May 2022 (% of total | Received three doses May 2022 (% of total | Cumulative number of deaths (% of total death) | No. of deaths with no. of vaccine doses (% of total death | |||
|---|---|---|---|---|---|---|---|---|
| None | 1 | 2 | 3 | |||||
| <3 | 123,600 | NA | NA | 1(0.0) | 1 (100) | 0 | 0 | 0 |
| 3–11 | 502,600 | 232,708 (46.3) | 181 (0.0) | 6 (0.1) | 5 (83.3) | 1 (16.7) | 0 | 0 |
| 12–19 | 447,300 | 383,916 (85.8) | 97,293 (21.8) | 5 (0.1) | 3 (60.0) | 1 (20.0) | 1 (20.0) | 0 |
| 20–29 | 771,900 | 722,683 (93.6) | 315,208 (40.8) | 14 (0.2) | 7 (50.0) | 1 (7.2) | 6 (42.8) | 0 |
| 30–39 | 1,094,500 | 1,043,025 (95.3) | 560,301 (51.2) | 25 (0.3) | 15 (60.0) | 3 (12.0) | 4 (16.0) | 3 (12.0) |
| 40–49 | 1,160,300 | 1,127,064 (97.2) | 728,673 (62.8) | 61 (0.6) | 37 (60.6) | 5 (8.2) | 15 (24.6) | 4 (6.6) |
| 50–59 | 1,191,300 | 1,111,784 (93.3) | 732,571 (61.5) | 247 (2.7) | 153 (61.9) | 27 (10.9) | 65 (26.3) | 2 (0.8) |
| 60–69 | 1,122,100 | 932,517 (83.1) | 573,073 (51.1) | 756 (8.3) | 493 (65.2) | 114 (15.1) | 133 (17.6) | 16 (2.1) |
| 70–79 | 591,300 | 436,542 (73.8) | 232,990 (39.4) | 1,529 (16.7) | 1037 (67.8) | 258 (16.9) | 213 (13.9) | 21 (1.4) |
| ≥80 | 398,200 | 212,282 (53.3) | 69,364 (17.4) | 6487 (71.0) | 4844 (74.7) | 1017 (15.7) | 593 (9.1) | 33 (0.5) |
|
|
|
|
|
|
|
|
|
|
aRate to the total in each age group.
COVID‐19 death case is defined as a death in a person with positive SARS‐CoV‐2 result and died within 28 days of the first positive specimen collection day. The underlying cause of death may have been unrelated to COVID‐19. The total death toll of 9133 includes two pending deaths, which are available from data sources.
(All the data are from https://www.coronavirus.gov.hk/pdf/5th_wave_statistics/5th_wave_statistics_20220508.pdf).
FIGURE 2The community movement of residents and the confirmed cases during the fifth wave of COVID‐19 in Hong Kong